Photocure says Asieris counterclaims in arbitration, seeks return of USD 6.6 million milestone payment

• Photocure faces an Asieris counterclaim in arbitration over an $11 million milestone tied to China approval of Cevira.
• Photocure invoiced $11 million; Asieris paid $6.6 million, arguing the China label does not trigger the full amount.
• Photocure filed arbitration on July 23 seeking the unpaid balance; Asieris’ Aug. 3 response seeks return of the $6.6 million.
• Photocure maintains the milestone was achieved, keeping the dispute centered on payment timing and contract interpretation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Photocure ASA published the original content used to generate this news brief via Cision (Ref. ID: 20260804:BIT:3962:0) on August 04, 2026, and is solely responsible for the information contained therein.